Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session VIII: Therapeutic Approaches to Front Line Ovarian Cancer
Debate: Should PARP Inhibators be the Standard of Care in the Frontline? - NO
Friday, September 23, 2022
12:15 PM – 12:25 PM
Debate Speaker(s)
Thomas J. Herzog, MD (he/him/his)
University of Cincinnati Cancer Center
Cincinnati, Ohio